What is the management and treatment for acute glaucoma diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management and Treatment of Acute Glaucoma

Acute angle-closure glaucoma is an ophthalmologic emergency requiring immediate medical therapy to lower intraocular pressure followed by definitive laser iridotomy within hours, not days. 1

Immediate Recognition and Triage

Acute angle-closure crisis (AACC) presents with:

  • Severe eye pain, headache, and nausea/vomiting 2
  • Markedly elevated intraocular pressure (often >40 mmHg) 2
  • Corneal edema, mid-dilated fixed pupil, and conjunctival injection 1
  • Visual symptoms including halos around lights and decreased vision 2

Even non-ophthalmologists can diagnose markedly elevated IOP by palpation of the globe—the affected eye feels rock-hard compared to the normal fellow eye. 2 Patients should be seen by an ophthalmologist without delay, ideally on the day of symptom onset. 2

Acute Medical Management

First-Line Medications (Initiate Immediately)

Medical therapy aims to rapidly lower IOP to relieve symptoms and clear corneal edema before definitive laser treatment. 1 Administer the following agents based on the patient's medical status:

Aqueous suppressants:

  • Topical beta-adrenergic antagonists (e.g., timolol 0.5%) 1
  • Topical alpha-2 agonists (e.g., brimonidine 0.2%) 1
  • Topical, oral, or IV carbonic anhydrase inhibitors (acetazolamide 500 mg IV initially, then 250 mg every 4 hours) 1, 3

Hyperosmotic agents for rapid IOP reduction:

  • Oral or IV hyperosmotic agents (mannitol 1-2 g/kg IV or oral glycerol) 1

Topical parasympathomimetics (miotics):

  • Pilocarpine 1-2% once IOP begins to decrease 1

Critical Medication Considerations

Important caveat: Aqueous suppressants may be initially ineffective because pressure-induced ciliary body ischemia reduces their ability to suppress aqueous formation. 1 Similarly, miotics are frequently ineffective when IOP is markedly elevated due to pressure-induced pupillary sphincter ischemia—they work better once IOP starts declining. 1

Avoid miotics in secondary pupillary block caused by intraocular gas, oil, vitreous, or lens-pupil block—in these cases, mydriatics may be more effective. 1

Definitive Treatment: Laser Peripheral Iridotomy

Laser peripheral iridotomy (LPI) is the preferred definitive treatment and should be performed as soon as the cornea clears enough to visualize the iris. 1 This is typically within hours of initiating medical therapy.

LPI Procedure Details

  • LPI relieves pupillary block by allowing aqueous to bypass the pupil, eliminating the pressure gradient between posterior and anterior chambers 1
  • Perform LPI in the superior iris (under the upper eyelid) to avoid visual symptoms 1
  • Confirm patency by visualizing zonules, anterior lens capsule, or ciliary processes through the iridotomy 1
  • Check IOP 30 minutes to 2 hours post-procedure 1

Post-LPI Management

  • Prescribe topical corticosteroids postoperatively to reduce inflammation 1
  • Perform dark-room gonioscopy with compression/indentation to assess extent of peripheral anterior synechiae (PAS) 1
  • Treat the fellow eye prophylactically with LPI because it has similar anatomic predisposition 1

Management of Persistent Elevated IOP After LPI

If IOP remains elevated after successful LPI, consider: 1

Trabecular damage from the acute attack:

  • PAS formation during iridocorneal apposition may have permanently damaged outflow 1
  • Goniosynechialysis (surgical lysis of synechiae) may improve outflow if performed within 6-12 months 1

Non-pupillary block mechanisms:

  • Plateau iris syndrome (persistent angle closure despite patent iridotomy) 1
  • Phacomorphic angle closure from lens enlargement 1
  • Superimposed open-angle glaucoma or pseudoexfoliation syndrome 1

Additional treatment options:

  • Chronic topical ocular hypotensive medications (same as primary open-angle glaucoma) 1
  • Laser iridoplasty to reopen appositionally closed angles 1
  • Cataract extraction alone can substantially lower IOP in many angle-closure patients and should be considered as a treatment option 1
  • Incisional surgery (trabeculectomy or tube shunt) if medical management fails 1

Alternative Acute Interventions

If medical therapy fails or the iris cannot be visualized for LPI: 1

  • Corneal indentation with a four-mirror gonioscopic lens, cotton-tipped applicator, or muscle hook tip may break pupillary block 1
  • Peripheral laser iridoplasty can be performed if the iris is visible but too edematous for iridotomy 1
  • Anterior chamber paracentesis for emergent IOP reduction 1
  • Surgical iridectomy if laser treatment is not feasible 1

Common Pitfalls to Avoid

  • Do not delay ophthalmology referral to perform additional testing—this is a same-day emergency 2
  • Do not rely solely on miotics when IOP is severely elevated; they will not work until pressure decreases 1
  • Do not forget to treat the fellow eye prophylactically—it has a 50% risk of acute attack within 5 years 1
  • Do not assume the problem is solved after LPI—up to 30% of patients require additional IOP-lowering treatment 1
  • Do not confuse this with open-angle glaucoma, which is chronic and asymptomatic, not an acute emergency 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute Closed-Angle Glaucoma-an Ophthalmological Emergency.

Deutsches Arzteblatt international, 2021

Research

Open-angle glaucoma.

American family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.